SS-31
Product Details
SS-31 — Research Peptide
SS-31, also known as Elamipretide, is a mitochondria-targeting tetrapeptide commonly studied for its interaction with mitochondrial membranes, cellular bioenergetics, and oxidative stress pathways. In laboratory settings, SS-31 has been researched for its potential role in mitochondrial function, ATP production, reactive oxygen species regulation, and cellular energy metabolism.
Scientific research has examined SS-31 for its affinity to cardiolipin, a phospholipid located within the inner mitochondrial membrane that is involved in maintaining mitochondrial structure and function. Studies have explored how SS-31 may influence mitochondrial stability, bioenergetic efficiency, and cellular stress responses in experimental models.
Published literature has investigated SS-31 in research related to mitochondrial dysfunction, oxidative stress mechanisms, and cellular metabolic signaling. Additional studies have explored its effects on mitochondrial respiration and energy production pathways under laboratory conditions.
This compound is supplied for qualified laboratory research and analytical purposes only.
Product Details
Product Name: SS-31
Alternative Name: Elamipretide
Form: Lyophilized peptide powder
Grade: Research use only
Application: Laboratory research and analytical testing only
Storage: Store in a cool, dry place under proper laboratory storage conditions.
Research Areas
This compound may be used in research related to:
- Mitochondrial function and bioenergetics studies
- Oxidative stress and reactive oxygen species (ROS) research
- Cellular energy metabolism investigation
- Cardiolipin interaction and mitochondrial membrane studies
- ATP production and mitochondrial respiration analysis
- Cellular stress response research
- Mitochondrial signaling and peptide pathway studies
Research References
- Szeto HH. “First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics.” British Journal of Pharmacology. 2014.
- Zhao K, Luo G, Giannelli S, Szeto HH. “Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis.” Biochemical Pharmacology. 2005.
- Birk AV, Chao WM, Bracken C, Warren JD, Szeto HH. “Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis.” British Journal of Pharmacology. 2014.
Lorem ipsum dolor ist amte, consectetuer adipiscing eilt. Aenean commodo ligula egget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quak felis, ultricies nec, pellentesque eu, pretium quid, sem.
